Managing active iupus nephritis during COVID-19 pandemic

We report safe management of patients with active LN with intense immunosuppression along with vigorous precautions amidst the COVID-19 pandemic. The role of hydroxychloroquine along with timely precautions needs to be further explored as protective measures against COVID-19 among systemic lupus erythematosus patients.

Source: Indian Journal of Nephrology - August 20, 2021 Category: Urology & Nephrology Authors: Joyita Bharati Manish Rathi Raja Ramachandran Aman Sharma Ritambhra Nada Harbir S Kohli Source Type: research